Results From the DoPING-HFpEF Trial: A Double Blind, Placebo-Controlled Randomized Cross-Over Trial Investigating Trimetazidine in Heart Failure With Preserved Ejection Fraction

被引：0
|
作者：
de Bovenkamp, Arno A. Van
Bakermans, Adrianus J. J.
Geurkink, Kiki J.
Oosterveer, Frank T.
De Man, Frances S.
Kok, Wouter E.
Nederveen, Aart J.
van Rossum, Albert C.
Handoko, M. Louis L.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12368
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Amantadine against dyskinesias in Parkinson's disease: a cross-over, double-blind, randomized placebo-controlled trial
    Sawada, H.
    Oeda, T.
    Kuno, S.
    Nomoto, M.
    Yamamoto, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 553 - 553
  • [42] MIDAS (Modafinil in Debilitating Fatigue After Stroke) A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial
    Bivard, Andrew
    Lillicrap, Thomas
    Krishnamurthy, Venkatesh
    Holliday, Elizabeth
    Attia, John
    Pagram, Heather
    Nilsson, Michael
    Parsons, Mark
    Levi, Christopher R.
    STROKE, 2017, 48 (05) : 1293 - 1298
  • [43] A Randomized Double-blind, Placebo-controlled, Cross-over Trial of Ganaxolone in Children and Adolescents with Fragile X Syndrome
    Tsai, Julia
    Ligsay, Andrew
    Van Dijck, Anke
    Kooy, Frank
    Hessl, David
    Bickel, Erika
    Hagerman, Randi
    Patroneva, Albena
    NEUROLOGY, 2017, 88
  • [44] Safety and efficacy of creatine supplementation in juvenile dermatomyositis: a randomized double-blind placebo-controlled cross-over trial
    Adriana Sallum
    Marina Solis
    Ana Paula Hayashi
    Guilherme Artioli
    Marcelo Sapienza
    Maria Otaduy
    Ana Pinto
    Clóvis Silva
    Rosa Pereira
    Bruno Gualano
    Pediatric Rheumatology, 12 (Suppl 1)
  • [45] Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double-blind, placebo-controlled cross-over trial
    Kanhai, Kawita M. S.
    Bijvank, Jenny A. Nij
    Wagenaar, Yorick L.
    Klaassen, Erica S.
    Lim, KyoungSoo
    Bergheanu, Sandrin C.
    Petzold, Axel
    Verma, Ajay
    Hesterman, Jacob
    Wattjes, Mike P.
    Uitdehaag, Bernard M. J.
    van Rijn, Laurentius J.
    Groeneveld, Geert Jan
    CNS NEUROSCIENCE & THERAPEUTICS, 2019, 25 (06) : 697 - 703
  • [46] The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: Results from a randomized, double-blind, placebo-controlled, cross-over trial
    Harte, Christopher B.
    Meston, Cindy M.
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (05): : 1184 - 1197
  • [47] Homeopathy for mental fatigue: lessons from a randomized, triple blind, placebo-controlled cross-over clinical trial
    Michael Emmans Dean
    Raj Karsandas
    J Martin Bland
    Debbie Gooch
    Hugh MacPherson
    BMC Complementary and Alternative Medicine, 12
  • [48] Homeopathy for mental fatigue: lessons from a randomized, triple blind, placebo-controlled cross-over clinical trial
    Dean, Michael Emmans
    Karsandas, Raj
    Bland, J. Martin
    Gooch, Debbie
    MacPherson, Hugh
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 12
  • [49] Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction A Randomized Controlled Trial
    Chieng, David
    Sugumar, Hariharan
    Segan, Louise
    Tan, Caleb
    Vizi, Donna
    Nanayakkara, Shane
    Al-Kaisey, Ahmed
    Hawson, Joshua
    Prabhu, Sandeep
    Voskoboinik, Aleksandr
    Finch, Sue
    Morton, Joseph B.
    Lee, Geoffrey
    Mariani, Justin
    La Gerche, Andre
    Taylor, Andrew J.
    Howden, Erin
    Kistler, Peter M.
    Kalman, Jonathan M.
    Kaye, David M.
    Ling, Liang-Han
    JACC-HEART FAILURE, 2023, 11 (06) : 646 - 658
  • [50] Randomized, Double-Blind, Placebo-Controlled Study of Sitaxsentan to Improve Impaired Exercise Tolerance in Patients With Heart Failure and a Preserved Ejection Fraction
    Zile, Michael R.
    Bourge, Robert C.
    Redfield, Margaret M.
    Zhou, Duo
    Baicu, Catalin F.
    Little, William C.
    JACC-HEART FAILURE, 2014, 2 (02) : 123 - 130
12345